share_log

思创医惠(300078.SZ):目前尚未直接开发DRG/DIP相关的产品或服务

Hangzhou Century (300078.SZ): Currently, we have not directly developed products or services related to DRG/DIP.

Gelonghui Finance ·  Jul 26 03:26

On July 26th, Gelonghui reported that Hangzhou Century (300078.SZ) stated on the investor platform that the company has not yet directly developed any products or services related to DRG/DIP. Currently, the company mainly provides single-disease data support through the construction of the national quality control platform in the DRG/DIP field. By collecting and managing single-disease data, it provides a solid foundation for national quality control management and research.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment